PIONEER Patient Testimonials
Read morePatient representatives, Erik Briers and Ken Mastris, reflect on the relevance of PIONEER for prostate cancer patients.
Introducing PIONEER Health Europa Quarterly
Read moreProfessor Dr James N’Dow explains how the PIONEER project will unlock the power of big data and big data analytics to transform the diagnosis and treatment of prostate cancer in Issue 8 of Health Europa Quarterly. To download the...
Job Advert: Research Associate Vita-Salute San Raffaele University in Milan
Read moreAn exciting 3 year opportunity has arisen for a talented research associate within work package 2 of PIONEER at the Vita-Salute San Raffaele University in Milan. The appointed researcher will work on the development and validation of a core...
Job Advert: Research Associate Prostate Cancer Outcomes
Read moreAn exciting opportunity has arisen for a talented research associate within work package 2 of PIONEER. The appointed researcher will work on the development of a core set of clinically relevant standardised prostate cancer-related outcomes and prognostic and diagnostic...
Wie Big Data bei Patienten mit Prostatakrebs helfen können
Read moreWie Big Data bei Patienten mit Prostatakrebs helfen können Innovative Medicines Initiative genehmigt 12 Millionen Euro umfassendes, öffentlich-privates Forschungsprojekt zur Verbesserung der Betreuung von Patienten mit Prostatakrebs. Die Innovative Medicines Initiative (IMI) hat PIONEER genehmigt. Dabei handelt es sich...
We need you – Patient involvement is vital to the success of PIONEER
Read moreA critical requirement of the PIONEER project is to agree on and prioritise the most important questions in Prostate cancer diagnosis and treatment that need answered for the next generation. The EAU Prostate Cancer Guideline Panel and other experts have...
Contact us here
PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. IMI2 receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
